ÂÜÀòÂÒÂ×

Cooper Collins is a seasoned executive with extensive experience in the biotech and pharmaceutical sectors. Currently, Collins serves as the Chief Executive Officer at Dominion Aesthetic Technologies, Inc., and as a Biotech Hedge Fund Manager at Sigma Bleyzer. Additional leadership roles include Chairman Of The Board at Fortis BioPharma and Board Member at TherapeuticsMD. Previously, Collins held the position of Chief Scientific Officer at Pernix Therapeutics, focusing on mergers and acquisitions to support strategic goals. A former CEO & President of the New Orleans Saints, Collins holds a Master of Business Administration from Nicholls State University, earned in 2003.